HELSINKI--(BUSINESS WIRE)--Leading Finnish BioIT company MediSapiens Ltd delivers the Helsinki University Central Hospital a web-based solution that enables more effective personalized medical treatment for leukemia patients based on individual drug response.
MediSapiens Ltd (http://medisapiens.com), the leading Finnish bioinformatics software developer, provides the hematology clinic of the Helsinki University Central Hospital with a custom-made software platform that allows taking advantage of biological information to create more effective personalized medical treatment for patients with acute leukemia. The treating physicians can use the platform to analyze genomic data to make more accurate personalized treatment decisions based on how the cancer cells of their patients respond to various drugs. The software is currently in trial use at the clinic, and a larger scale deployment will take place during the year 2016.
